Last Week in Medicine
Avsnitt

Bleeding Risk with Apixaban vs Rivaroxaban for Acute VTE (COBRRA), Left Atrial Appendage Closure vs Medical Therapy for Atrial Fibrillation (CLOSURE-AF)

Last Week in Medicine
Dela

We are back with a landmark trial -- COBRRA was finally published! Apixaban wins again, but is rivaroxaban done for good?? 

Also, is left atrial appendage occlusion safer than oral anticoagulation in patients with a high risk of stroke and a high risk of bleeding? Check it out!

Apixaban vs Rivaroxaban for Acute VTE (COBRRA)

Left Atrial Appendage Closure vs Medical Management (CLOSURE-AF)


Music from Uppbeat (free for Creators!):

https://uppbeat.io/t/soundroll/dope

License code: NP8HLP5WKGKXFW2R

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Stephen Jenkins, MD, Austin Rupp, MD. Innehållet i podden är skapat av Stephen Jenkins, MD, Austin Rupp, MD och inte av, eller tillsammans med, Poddtoppen.